Skip to content
Neuromyelitis News logo
  • About NMOSD
    What is NMOSD?
    Causes
    Symptoms
    Diagnosis
  • Treatments
    Approved treatments
  • News
  • Columns
    The Beginner’s Guide to Walking — Jennifer V.
    Archived Columns
    • Courage to Care — Candice Galvan
    • Strength of the Soul — Mileidys Almaguer Iniguez
    • The View From Here — Lelainia Lloyd
  • What can we help you find today?

April 21, 2022 News by Marta Figueiredo, PhD

Clinical Efficacy of Soliris Supported by Pharmacological Analysis

An analysis of pharmacological data supports the observed clinical efficacy of Soliris (eculizumab) in significantly reducing relapses in patients with neuromyelitis optica spectrum disorder (NMOSD) given the therapy in the PREVENT Phase 3 clinical trial. At its approved dose, Soliris led to rapid, sustained, and complete suppression…

February 3, 2021 News by Steve Bryson, PhD

Autoimmune Marker CH50 May Be Useful Measure of Soliris Efficacy

The autoimmune biomarker CH50 was directly impacted by treatment with Soliris (eculizumab) in three people with neuromyelitis optica spectrum disorder (NMOSD), a case report has shown. According to researchers, this suggests that CH50 may be a useful…

Recent Posts

  • When eye shadow and fingernail polish are types of treatment
  • Disability, depression after NMOSD diagnosis likely lead to job changes
  • How I’m processing ongoing trauma by creating space for myself
  • Eye scans may be helpful tool to distinguish NMOSD, MS in patients
  • Ultomiris found safe, effective in complex NMOSD cases: Study
  • The importance of routines in managing my NMOSD
  • Bio-Thera to file for BAT4406F’s approval for NMOSD in China
  • Playing tourist in Toronto reminded me that it’s not very accessible
  • AI model analyzes images of eye to help accurately diagnose NMOSD
  • What coping with chronic illness and disability looks like


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.